Ricopili associated_with Psychiatric Genomics Consortium
Evidence from:
primary |
all sources
Evidence (1 sources)
Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder.
(2019)
PMID:30478444
cited
Quality control, imputation and primary association analyses were done using the bioinformatics pipeline Ricopili, developed by the Psychiatric Genomics Consortium (PGC).
confidence: 0.95